The iconic producer of (mostly) sweet carbonated soft drinks has released its results for Q4 FY2025, along with its sales outlook for 2026. The results are not disastrous; however, investor reaction clearly suggests disappointment.
Quarterly view:
EPS fell to $0.58, which nevertheless came in above market expectations of around $0.56.
Revenue also declined.this time by more than the market had expected, to $11.8 billion versus investor expectations of $12 billion.
On a year-over-year basis, EPS increased by 4%, and the fact that the figure came in above the analyst consensus points to exceptionally effective cost management. Revenue also rose year over year, though by only 2%.
Sales volume increased by 1%, with growth in the U.S., Japan, and Brazil. The company also managed to raise prices, with the average annual price increase at 4%.
Management communicated a number of important operational and strategic decisions. The incoming CEO and current COO, Henrique Braun, pointed to demand-side pressures, which the company is addressing by offering new package sizes tailored to less affluent customers.
What may have worried shareholders the most is the 2026 sales outlook. Organic revenue growth is expected to come in at 4–5%, while profits are projected to rise by 7–8%. These are not particularly dynamic growth forecasts, and the market is still uncertain about how the company will handle the fundamental pressure stemming from changing consumer habits.
COKE.US (D1)
Source: xStation5
Gold surges 2% amid weakening US Dollar 📈
War-related shifts in the Forex market: USD plummets 💥; AUD, NZD and the CHF rebound 🚀
NZDUSD: hawkish RBNZ decision and TACO trade support the NZD 🚀
Oil plunges 10% 📉
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
